Transforming The Treatment of Schizophrenia: Design and Development of AMPA Receptor Modulators with a Much Improved Safety Profile as Novel Drugs for Treating the Cognitive Dysfunction Associated with Schizophrenia and Other CNS Disorders (Joint with University of Sussex) (Late Stage Seeding Discovery Award)

Effective start/end date1/08/1430/09/20


  • Wellcome Trust (via Sussex): £192,685.00
  • Wellcome Trust (via Cardiff): £80,401.24